Dr. Al- Qasabi Inaugurates The First World Conference on "Modern Trends in Hematology" at KFSH




H.E. Dr. Qasim Al-Qasabi, Chief Executive Officer of King Faisal Specialist Hospital and Research Centre (KFSHRC), affirmed that the hospital is a leader and pioneer centre in the Middle East, providing the all necessary medical services such as Organ and Bone Marrow Transplantation, Medical Genetics, Neuroscience, Cardiac Center as well as Pediatric and Adults Hematology and Oncology.

Dr. Al-Qasabi explained in his opening speech on Tuesday  November 1st 2016 that KFSH&RC receives yearly 160 patients of pediatric hematology, as well as 16 cases of pediatric histiocytic disorders, and these statistics are through the recent five years, resulting in increased number of Bone Marrow Transplant for children.

He pointing out that the last year witnessed the establishment of Benign Tumors Diseases Registry Centre as the first centre of its kind in the Kingdom of Saudi Arabia, providing the hospital with information to develop the therapy plans and the medical researchers in this field.   

That came during the first world conferencet organized by the hospital for discussing the new trends on treating the genetic and acquired hematology.

Dr. Mahasen Al- Saleh, Section Head and Consultant, Pediatric Hematology / Oncology, and Head of the organizing committee said, “60 speakers from KSA, USA, Canada, Germany, Britain, Ireland, India, Oman and Lebanon attended the three-day events and participate therein with 65 Scientific papers, discussing the latest matters on medication of Hematology, Histiocytic Disorders, genetic and acquired Bone Marrow Failure Syndrome, Hemophilia, Thrombosis, different types of Anemia and genetic causing Hemophilia, and on blood transfusion usage and products for treating various types of Anemia”.

She pointed out that the third day of the conference included four medical workshops, discussing Hematology, Dentistry, Feeding and Nursing and blood transfusion.

It is worth mentioning that the Saudi Commission for Health Specialties determined 30 continuing medical education (CME) hours for attending the conference and the workshops.